Evidence map›Paper›PMID 37763782›Full record

Trial reportMedicina (Kaunas, Lithuania)2023

Effects of Aphrodite (an Herbal Compound) on SSRI-Induced Sexual Dysfunctions and Depression in Females with Major Depressive Disorder: Findings from a Randomized Clinical Trial.

Nasrin Shahmoradi, Omran Davarinejad, Annette Beatrix Brühl, Serge Brand

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 4 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Effects of Shatavari (International journal of women's health · 2026
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Nasrin ShahmoradiDepartment of Psychiatry, Kermanshah University of Medical Sciences (KUMS), Kermanshah 6714673159, Iran.
Omran DavarinejadDepartment of Psychiatry, Kermanshah University of Medical Sciences (KUMS), Kermanshah 6714673159, Iran.
Annette Beatrix BrühlDepartment of Psychiatry, Kermanshah University of Medical Sciences (KUMS), Kermanshah 6714673159, Iran.ORCID 0000-0003-4704-4986
Serge BrandCenter for Affective, Stress and Sleep Disorders, Psychiatric Clinics of the University of Basel, 4002 Basel, Switzerland.ORCID 0000-0003-2175-2765
Kermanshah University of Medical Sciences · IRUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Major Depressive DisorderSexual Dysfunction, PhysiologicalAdultDepressionDouble-Blind MethodFemaleHumansSelective Serotonin Reuptake InhibitorsSertralineSelective Serotonin Reuptake InhibitorsSertralineanxietyAphroditecinnamongingerherbal medicinemajor depressive disordersaffronsertralinesexual dysfunctionssleep disturbancesSSRI-induced sexual dysfunctionthistleTribulus terrestris

Identifiers

PMID37763782
PMCPMC10538161
OpenAlexW4386779334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.